EXP vs REGN · P/E 16, rev $2.26B vs P/E 14, rev $14.34B
Eagle Materials Inc (EXP) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Eagle Materials Inc (EXP) is a building materials company listed on NYSE.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported EXP revenue for 2025-03-31 was $2.26B. Net income was $463.4M. Revenue was up 0.1% from 2024-03-31 to 2025-03-31. EXP currently screens at market cap $6.59B and trailing P/E 16.2.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
EXP currently screens at market cap $6.59B and trailing P/E 16.2. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the EXP and REGN stock pages for the full models.
Not investment advice.